Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Gijsen

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|May 9, 2025
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation StudyNada Dia, Sabrina De Winter, Matthias Gijsen, et al.
Therapeutic Drug Monitoring|December 3, 2024
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation StudyNada Dia, Sabrina De Winter, Matthias Gijsen, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2022
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenationBeatrijs Mertens, Ruth Van Daele, Yves Debaveye, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropeniaMatthias Gijsen, Britt Bekkers, Johan Maertens, et al.
Infection and Drug Resistance|January 17, 2022
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal FunctionMatthias Gijsen, Omar Elkayal, Pieter Annaert, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature ReviewBeatrijs Mertens, Omar Elkayal, Erwin Dreesen, et al.
British Journal of Clinical Pharmacology|March 24, 2026
Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and childrenZoë Vander Elst, Pieter-Jan Spiessens, Dorian Vanneste, et al.
Mycoses|February 18, 2026
Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole-N-Oxide ExposureJanne Hubrechts, Matthias Gijsen, Katelijne Floré, et al.
Microorganisms|October 23, 2021
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill PatientsRuth Van Daele, Joost Wauters, Katrien Lagrou, et al.
Critical Care Medicine|October 13, 2020
Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance PredictorMatthias Gijsen, Chao-Yuan Huang, Marine Flechet, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|May 9, 2025
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation StudyNada Dia, Sabrina De Winter, Matthias Gijsen, et al.
Therapeutic Drug Monitoring|December 3, 2024
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation StudyNada Dia, Sabrina De Winter, Matthias Gijsen, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2022
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenationBeatrijs Mertens, Ruth Van Daele, Yves Debaveye, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropeniaMatthias Gijsen, Britt Bekkers, Johan Maertens, et al.
Infection and Drug Resistance|January 17, 2022
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal FunctionMatthias Gijsen, Omar Elkayal, Pieter Annaert, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature ReviewBeatrijs Mertens, Omar Elkayal, Erwin Dreesen, et al.
British Journal of Clinical Pharmacology|March 24, 2026
Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and childrenZoë Vander Elst, Pieter-Jan Spiessens, Dorian Vanneste, et al.
Mycoses|February 18, 2026
Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole-N-Oxide ExposureJanne Hubrechts, Matthias Gijsen, Katelijne Floré, et al.
Microorganisms|October 23, 2021
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill PatientsRuth Van Daele, Joost Wauters, Katrien Lagrou, et al.
Critical Care Medicine|October 13, 2020
Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance PredictorMatthias Gijsen, Chao-Yuan Huang, Marine Flechet, et al.
Pageof 5